Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accounts Payables (2016 - 2017)

Historic Accounts Payables for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $579386.0.

  • Tenax Therapeutics' Accounts Payables fell 5839.46% to $579386.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $579386.0, marking a year-over-year decrease of 5839.46%. This contributed to the annual value of $727599.0 for FY2016, which is N/A changed from last year.
  • As of Q3 2017, Tenax Therapeutics' Accounts Payables stood at $579386.0, which was down 5839.46% from $434195.0 recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Accounts Payables ranged from a high of $1.5 million in Q2 2016 and a low of $434195.0 during Q2 2017
  • In the last 4 years, Tenax Therapeutics' Accounts Payables had a median value of $972483.0 in 2015 and averaged $979723.0.
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 8001.95% in 2013, then crashed by 7146.22% in 2017.
  • Quarter analysis of 4 years shows Tenax Therapeutics' Accounts Payables stood at $977162.0 in 2013, then dropped by 0.48% to $972483.0 in 2015, then decreased by 25.18% to $727599.0 in 2016, then dropped by 20.37% to $579386.0 in 2017.
  • Its Accounts Payables was $579386.0 in Q3 2017, compared to $434195.0 in Q2 2017 and $1.4 million in Q1 2017.